Company · CIK 0001582313 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Xenon Pharmaceuticals Inc. · XENE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 MForm 4 → | Sep 3, 8:26 pm EDT | Dawn SvoronosDirector | 5,144 | $8.15 | $41,924 | 31,373 | — | |
| Aug 28, 2026 SForm 4 → | Aug 31, 9:59 pm EDT | Christopher John KenneyChief Medical Officer | 7,068 | $60.25 | $425,829 | 2 | −100.0% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 MForm 4 → | Sep 3, 8:26 pm EDT | Dawn SvoronosDirector | 5,144 | — | — | 0 | — |